Thiazovivin CAS: 1226056-71-8

CAS NO: 1226056-71-8
Thiazovivin
Chemical Name: Thiazovivin
Molecular Formula: C15H13N5OS
Formula Weight: 311.36
CAS No.: 1226056-71-8
Description Review
Description

Thiazovivin is a synthetic small molecule that is used as a selective inhibitor of the Rho-associated protein kinase (ROCK) signaling pathway. ROCK signaling plays a crucial role in cell survival, differentiation, proliferation, and cell shape. Thiazovivin acts as an inhibitor of ROCK signaling, leading to a change in cellular behavior, including stem cell differentiation and maintenance. Thiazovivin has been found to exert beneficial effects in the treatment of a range of diseases including heart disease, cancer, and neurological conditions.

Chemical name: 2-(3-Morpholinyl)-6-(1-thioxo-1,2,6-thiadiazinan-4-yl)pyrimidin-4(3H)-one Molecular formula: C12H15N5O2S2 Formula weight: 317.42 g/mol CAS No: 1226056-71-8

Top Ten Keywords from Google and Synonyms:

  1. RhoA kinase inhibitors
  2. Thiazovivin
  3. Thiazolidinones
  4. ROCK inhibitors
  5. Small molecules
  6. Cell culture
  7. Differentiation
  8. Disease treatment
  9. Stem cell culture
  10. Immunology

Synonyms: N-(6-(1-thioxo-1,2,6-thiadiazinan-4-yl)-2-(morpholino)pyrimidin-4-yl)acetamide

Health Benefits of Thiazovivin: Thiazovivin has been shown to have a range of useful health benefits. It has been studied for its potential use in treating heart disease, cancer, and neurological conditions. For example, thiazovivin has been shown to be effective in promoting the differentiation of stem cells, which could be useful in the treatment of neurological conditions such as Parkinson's disease. Additionally, thiazovivin has demonstrated anti-tumor properties and has been shown to be effective in reducing the size of tumors in mice models.

Potential Effects: The effects of thiazovivin are primarily achieved through its inhibition of the Rho-associated protein kinase (ROCK) signaling pathway. By inhibiting this pathway, thiazovivin can modulate cell behavior and differentiation. Thiazovivin has been found to be effective in promoting the differentiation of stem cells, which offers a range of potential therapeutic applications. Thiazovivin has also demonstrated anti-tumor properties, which may make it an effective treatment for cancer.

Product Mechanism: Thiazovivin inhibits the activity of Rho-associated protein kinase (ROCK) signaling by selectively targeting ROCK1 and ROCK2. This leads to reduced cell contractility, decreased migration of cells, and modulated cell growth and differentiation. Through this mechanism, thiazovivin impacts stem cell differentiation, tumor cell migration, and various other cellular functions.

Safety: Thiazovivin has demonstrated relatively low toxicity in various studies. However, as with all medications, it is important to consult with a healthcare provider prior to taking thiazovivin, particularly if you have any pre-existing medical conditions that may be impacted by its use.

Side Effects: Thiazovivin has been found to be relatively safe, but there may still be some side effects associated with its usage. For example, some animal studies have suggested that thiazovivin may cause embryo toxicity, which could limit its use in pregnant women. Additionally, thiazovivin may cause reduced platelet aggregation and bleeding, so individuals who have a bleeding disorder should exercise caution when considering taking thiazovivin.

Dosing Information: The dosing of thiazovivin varies greatly depending on the specific condition being treated and the individual patient. As with all medications, it is important to follow dosing instructions closely and to be aware of any potential side effects.

Conclusion: Thiazovivin is a synthetic small molecule that acts as a selective inhibitor of the Rho-associated protein kinase (ROCK) signaling pathway. Its effects are primarily achieved through the inhibition of ROCK1 and ROCK2, leading to benefits such as enhanced stem cell differentiation and anti-tumor properties. While thiazovivin has demonstrated relatively low toxicity, it is important to consult with a healthcare provider prior to taking thiazovivin to ensure that it is a safe and appropriate treatment for your specific condition.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code